Global Equine Pharmaceuticals and Supplements Competitive Landscape Professional Research Report 2024
Research Summary
Equine pharmaceuticals and supplements refer to a category of products specifically developed for the health and well-being of horses. These include a wide range of medications, treatments, and dietary supplements designed to address various equine health concerns and nutritional needs. Equine pharmaceuticals can encompass prescription drugs used to treat illnesses, infections, or injuries in horses, while supplements are typically non-prescription products used to support overall health, performance, and specific nutritional requirements. Common equine supplements include vitamins, minerals, joint supplements, digestive aids, and herbal remedies. The use of equine pharmaceuticals and supplements is essential in maintaining the health, performance, and longevity of horses, and their application can vary widely based on the individual horse's needs, activity level, and health conditions. These products are an integral part of modern equine healthcare and management.
According to DIResearch's in-depth investigation and research, the global Equine Pharmaceuticals and Supplements market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Equine Pharmaceuticals and Supplements include Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Equine Pharmaceuticals and Supplements. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Equine Pharmaceuticals and Supplements market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Equine Pharmaceuticals and Supplements market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Equine Pharmaceuticals and Supplements industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Equine Pharmaceuticals and Supplements Include:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Equine Pharmaceuticals and Supplements Product Segment Include:
Saddles and accessories
Bridles & Attachments
Halters
Bits
Blankets
Protection Boots & Wraps
Hoods
Stirrups
Equine Pharmaceuticals and Supplements Product Application Include:
Children
Adults
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Equine Pharmaceuticals and Supplements Industry PESTEL Analysis
Chapter 3: Global Equine Pharmaceuticals and Supplements Industry Porter’s Five Forces Analysis
Chapter 4: Global Equine Pharmaceuticals and Supplements Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Equine Pharmaceuticals and Supplements Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Equine Pharmaceuticals and Supplements Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources